WHO ICTRP trial
Based on HSP70/NF-?B/Caspase3 signaling pathway to explore the clinical…
ITMCTR2200005785 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting
Key facts
| Trial ID | ITMCTR2200005785 |
|---|---|
| Public title | Based on HSP70/NF-?B/Caspase3 signaling pathway to explore the clinical mechanism of Cangfu Daotan Prescription in patients with phlegm-dampness polycystic ovary syndrome |
| Scientific title | Study on TCM Syndrome of Phlegm-Dampness PCOS Infertility Based on Follicular Fluid Proteomics |
| Primary sponsor | Affiliated Hospital of Shandong University of Traditional Chinese Medicine |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Polycystic ovary syndrome |
| Interventions | three:the placebo;one:Cangfu phlegm guide soup intervention;two:the placebo |
| Registration date | Mar 30, 2022 |
| Target size | three:33;one:33;two:33 |
| Secondary IDs | ChiCTR2200058119;ChiMCTR2200005785 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: